A fter a chronic increase in blood pressure, arteries undergo alterations of endothelial (ECs) and smooth muscle cells (SMCs) because of hemodynamic changes.
A fter a chronic increase in blood pressure, arteries undergo alterations of endothelial (ECs) and smooth muscle cells (SMCs) because of hemodynamic changes. 1 Specifically, hypertension results in the hypertrophic remodeling of arterial walls, 2, 3 which associates with altered expression of connexins (Cxs). [4] [5] [6] [7] [8] These proteins form channels for the communication of ECs and SMCs, which is needed to coordinate vasoconstriction and vasodilation along the vessels. 9 ECs predominantly express Cx37 and Cx40, [5] [6] [7] whereas SMCs mostly express Cx43 and Cx45. 5, 6, 10 Mice lacking Cx40 feature hypertension 4, 6, 11, 12 because of increased secretion of renin 4, 13 and reduced relaxation of peripheral vessels. 14 This effect may be the link to the decreased expression of endothelial nitric oxide synthase (eNOS), 5, 15 which impairs the release of NO, whereby ECs usually relax SMCs. [4] [5] [6] 13 Thus, restoration of Cx40 in ECs of Cx40−/− mice normalizes eNOS levels, 8 suggesting an interaction between these proteins. As yet, however, such interaction has not been tested during hypertension.
To investigate this question, we have subjected wild-type (WT) and Cx40-null mice (Cx40−/−) 4, 13 to conditions inducing hypertension by either volume overload (after a 1-kidney, 1-clip [1K1C] procedure 16, 17 ) or renin overproduction (after a 2-kidney, 1-clip [2K1C] procedure 6 ). We show that Cx40 consistently increased in aortic ECs, whereas Cx37 and Cx45 increased in SMCs, irrespective of the mechanism leading to hypertension. In contrast, Cx43 only increased in SMCs during renin-dependent hypertension. The volume-dependent hypertension of WT mice was associated with an increased interaction between Cx40 and Cx37 with eNOS, whereas Cx40−/− null mice featured decreased levels of eNOS and increased phosphorylation of the enzyme. The results provide evidence that Cx40 and Cx37 of ECs activate different signaling mechanisms depending on the cause of hypertension. the presence of normal circulating levels of renin (Table S2) , renal expression of the enzyme (Table S3 and Figure S1 ), and expression of the AT1a angiotensin II receptors (Table S3 ). The data show that the 1K1C procedure resulted in chronic hypertension, affecting the aorta independently of renin signaling.
In the hypertensive Cx40−/− mice, the 1K1C procedure increased blood pressure and cardiac weight index because of the association of renin-dependent and -independent mechanisms (Table S2) . Thus, these mice featured aortic and renal alterations similar to those observed in the untreated Cx40−/− mice (Tables S2 and S3 ). Cx40−/− mice submitted to a unilateral nephrectomy in the absence of arterial clipping (sham group) featured a drop in the circulating levels of renin which did not change other parameters (Tables S2 and S3 ). The data show that the 1K1C procedure did not alter most characteristics of Cx40−/− mice.
2K1C Procedure Induces Renin-Dependent Hypertension
The 2K1C treatment increased the blood pressure, cardiac index, renin levels, and aorta thickness of WT mice, approaching the values observed in the untreated Cx40−/− mice (Table  S4 ). The data show that the 2K1C procedure mimicks the renin-dependent hypertension of mice lacking Cx40.
Volume-and Renin-Dependent Hypertension Differentially Regulates Aortic Connexins
The expression of Cx40 was higher in the aortas of hypertensive 1K1C and 2K1C mice than in those of the corresponding WT controls ( Figure 1A ; Figure S2 ). The protein was restricted to ECs, and this distribution was not altered by hypertension (Figure 1B and 1C ; Figure S3 ).
The expression of Cx37 was also increased in the aortas of the hypertensive Cx40−/− and was not further modified by the 1K1C procedure (Figure 2A ; Figure S2 ). Western blots of SMC-and EC-enriched samples showed that Cx37 increased in the SMCs of all hypertensive models ( Figure 2B ; Figure S3 ), although decreasing in the ECs of Cx40−/− mice ( Figure 2B and 2C) . Immunostaining revealed that the protein was restricted to ECs of control mice, but was also found in the SMCs of Cx40−/−, 1K1C, and 2K1C mice ( Figure 2D ; Figure S3 ).
The expression of Cx43 by SMCs ( Figure S3 and S4) increased in the aortas of Cx40−/−, Cx40−/− 1K1C, and WT 2K1C mice ( Figure S2 and S4). The expression of Cx45 was increased in all hypertensive animals ( Figure S2 and S4). The data document a differential regulation of aortic connexins under various hypertensive conditions. 
Function of eNOS Increases in 1K1C Mice
By immunofluorescence, most Cx40 and Cx37 were detected at the periphery of ECs (Figures 1 and 2; Figures S3, S5 , and S7), whereas most eNOS was found in their cytoplasm ( Figure S5 ). The expression of this enzyme was similar in all WT mice, but decreased in Cx40−/− mice ( Figure 3A) . The phosphorylation of eNOS at Ser-1177 (P-eNOS) was similar in the aortas of WT 1K1C and 2K1C mice (Figure 3 ; Figure S6 ), but increased in the aorta of Cx40−/− 1K1C mice ( Figure 3A) . These changes, which were paralleled by alterations in Akt levels ( Figures 3B; Figure S6 ), decreased and increased the production of NO in Cx40−/− mice ( Figure 3C ) and in WT 1K1C and Cx40−/− 1K1C mice ( Figure 3C ), respectively.
A tight association between eNOS and Cx40 was detected in both the cytoplasm and the membrane of ECs of WT ( Figures S7A and S8 ), but not of Cx40−/− mice (data not shown). This interaction increased in the ECs of WT 1K1C ( Figure S7A ), but not of 2K1C mice ( Figure S8 ).
Comparable observations were made with regard to the interaction between Cx37 and eNOS ( Figures S7B and S8) . Again, this interaction increased in WT 1K1C mice ( Figure  S7B ), but not in WT 2K1C animals ( Figure S8 ). Because of the downregulation of Cx37 after loss of Cx40 (Figure 2 ), this interaction was less abundant in the ECs of Cx40−/− mice ( Figure S7B ).
Discussion
The connexins expressed by ECs and SMCs have been implicated in the physiological function of arteries 5, 7 and their adaptation to chronic patho-physiological conditions, 10, 18, 19 specifically hypertension. 6, 20, 21 Still, it is not clear whether vascular Cx are similarly changed in all forms of hypertension, 22 and, if so, how these changes affect blood pressure.
Mice lacking Cx40 are chronically hypertensive because of increased secretion of renin 4, 13 and altered vasomotor tone, 14, [23] [24] [25] which was attributed to either the loss of Cx40, the concurrent downregulation of Cx37 in ECs, 5, 25, 26 or the upregulation of Cx43 in the SMCs. 6, 21 The selective restoration of Cx40 in the renin-secreting cells reduced hypertension by decreasing renin secretion, whereas the Cx40 reexpression in ECs allowed for the normalization of Cx37 and eNOS without affecting blood pressure, suggesting that the coordinated Cx expression is altered during hypertension. 8 To gain insights into this coordination, we first compared Cx changes in models of renin-dependent and -independent hypertension. 4, 6, 16, 17 We show that all hypertensive mice featured higher levels of Cx40 in ECs and of Cx37 and Cx45 in SMCs. In contrast, the expression of Cx43 was upregulated only under conditions of renin-dependent hypertension. 6 The data show that various Cxs differently change depending on the mechanism increasing blood pressure. The resulting vessel adaptation consistently induced the expression of Cx37 in SMCs by a mechanism which remains to be addressed. This change could reflect a loosening of the correlation between Cx40 and Cx37 expression 6, 8 or an altered phenotype of the SMCs which, after prolonged hypertension, penetrate the intimal layer of vessels. [1] [2] [3] 9, 10 Second, we focused on the relationship between Cxs and eNOS, 5, 8, 15 a key EC enzyme for the production of NO, which relaxes SMCs, thus contributing to the control of blood pressure. 5, 14, 22, 25 We now show that volume-dependent hypertension promotes the interaction of Cx40 and Cx37 with eNOS and that this interaction results in increased release of NO. Our data suggest that this interaction starts during the cytosolic trafficking of connexins, raising the possibility that it may be facilitated with partially oligomerized Cxs or individual connexons. How this interaction is established with Cx40 and Cx37 remains to be assessed. By analogy with other proteins targeted by NO, eNOS may react with a cysteine residue of the connexins, consistent with the finding that Cxs can be post-translationally nitrosylated. [27] [28] [29] [30] Our findings further document that, although volume-and renin-dependent hypertension similarly increased Cx levels, the abundance of Cx-eNOS complexes differed with the cause of hypertension. Given that angiotensin-II uncouples eNOS and decreases its levels via different signaling pathways, 31, 32 it is plausible that these pathways be also differently regulated in renin-and volume-dependent models of hypertension, possibly accounting for the apparent discrepancy mentioned above. The observation that hypertensive 1K1C mice display altered the relaxation of resistance arterioles 16 suggest that the increase in NO resulting from the Cx-eNOS interaction is a compensatory reaction, mitigating the increase in blood pressure induced by volume overload. An analogous explanation could account for the report that Tie2-Cx40 mice, which express Cx40 only in ECs and feature control levels of eNOS, were still as hypertensive as Cx40−/− mice. 8 In this model, the normal levels of eNOS presumably ensure a normal arterial relaxation, contributing to counteract the increased blood pressure resulting from the loss of Cx40 in the renin-secreting cells. 8 The association of volume-and renin-dependent hypertension increased by ≈10% the blood pressure of Cx40−/− mice. Under these conditions, we observed an increased phosphorylation of eNOS which by enhancing the activity of the enzyme 33,34 could mitigate the reduced interaction between Cx and eNOS, resulting from the nil (Cx40) to lower (Cx37) levels of the former proteins. Further studies should directly test this possibility, inasmuch as WT 1K1C mice showed increased binding of Cx37/Cx40 to eNOS and increased NO production, in spite of a constant Ser 1177 phosphorylation of eNOS.
In summary, the new data provide a plausible scenario for the involvement of vascular connexins in hypertension ( Figure  S9 ). The emerging mechanism is that loss of Cx40, which also reduces the expression of Cx37, decreases the interaction of these 2 Cxs with eNOS, reducing the production of NO which, in turn, fails to sufficiently relax the wall of resistance arteries. This effect enhances the amplitude of renin-dependent hypertension, which is mostly caused by the direct transcriptional control of the renin gene by Cx40. On the other hand, the reconstitution of Cx40 in ECs, as well as the over expression of this connexin in ECs, leads to restored expression of Cx37, favoring the close interaction of Cxs with eNOS and the subsequent increase in NO production.
Perspectives
Future work should investigate how Cx37 and Cx40 interact with eNOS. What Is New?
• We submitted renin-dependent hypertensive connexin (Cx) 40 null mice to a model of volume-dependent hypertension and document that Cx40 controls the expression and phosphorylation of endothelial nitric oxide synthase.
What Is Relevant?
• Cx40 null mice are hypertensive because of increased renin secretion and altered vasomotor tone as a result of reduced NO production. We show that, in the absence of Cx40, the combination of volume and renin-dependent hypertension altered the expression of endothelial nitric oxide synthase and its phosphorylation, providing for a mechanism whereby Cxs contribute to control blood pressure. 
METHODS

Animals and surgery
The generation of Cx40-/-mice and their genotypic characterization have been described [1] [2] [3] . Briefly, breeding pairs of Cx40-/-mice were crossed with C57/Bl6. Mice were identified by PCR of genomic DNA, using the following primers: for the Cx40 recombinant allele (494 bp amplicon), 5'-GGATCGGCCATTGAACAAGATGGATTGCAC-3' (sense) and 5'-CTGATGCTCTTCGTCCAGATCATCCTGATCG-3' (anti-sense); for the Cx40 wild type allele (314 bp amplicon), 5'-GGGAGATGAGCAGGCCGACTTCCGGTGCG-3' (sense) and 5'-GTAGGGTGCCCTGGAGGACAATCTTCCC-3' (antisense). All mice were housed under pathogen-free conditions, as per our institutional guidelines. Control mice were C57/Bl6. Mouse care, surgery and euthanasia procedures were approved by our institutional committee for animal experiments, and the Lausanne veterinary office (authorization 31.1.1008/1993/I). The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (8th Edition, 2011). One-kidney, one clip (1K1C) hypertension was induced in WT and Cx40-/-male mice (10 weeks) by removing the right kidney and placing a U-shaped silver clip of 0.12 mm internal diameter over the left renal artery 4 . Control mice were nephrectomized but had no renal artery clipping. For the two-kidney, one clip model (2K1C), the left renal artery was clipped as mentioned above [2] [3] [4] [5] .
Animal monitoring
Four weeks after surgery, the mean blood pressure (MBP), heart rate and plasma renin were measured as previously described 4 . Briefly, one day before sacrifice, the right carotid artery of anesthetized mice was penetrated with a catheter connected to a pressure transducer and a computerized data acquisition system 2, 3, 6 . This system records every 20 sec the heart rate, as well as the diastolic and systolic pressure of conscious mice. Data are shown as the mean (MBP) of the diastolic and systolic values. After a 30 min recording period, 300 µL blood was collected in EDTA-coated tubes and centrifuged at 4°C. Plasma was then stored at -80°C. In some experiments, MBP was measured on conscious mice by a non-invasive, computerized tail-cuff method (BP-2000, Visitech Systems) 1, 7 . Initially, mice were pre-trained during 7 days, and then pulse rate and blood pressure were recorded by an automatic system of cuff inflation and deflation, over a 10 day period. No consistent differences in MBP were observed between the values given by the 2 measurement methods (data not shown). Plasma renin activity was measured by trapping of an antibody against angiotensin I (AngI). Briefly, aliquots of plasma samples were incubated for 15 min at 37°C in the presence of a renin substrate, and a defined amount of a rabbit serum against AngI. The amounts of AngI produced during the incubation period was then determined using a sensitive radioimmunoassay.
Aorta analysis
At the end of the experiment, mice were euthanized and immediately infused through the left ventricle with 5 mL phosphate-buffered saline (PBS). The aortas were then excised for cryosectioning. The combined thickness (intima plus media) and the internal diameter of the aorta were measured using a semi-automatic set-up RNA and protein analysis Aortas and kidneys were carefully removed, rapidly reduced to powder into liquid nitrogen, and stored at -80°C. For RT-PCR analysis, the powder was homogenized in Tripure Isolation Reagent (Roche, Switzerland), and total RNA was extracted according to the manufacturer's instructions 1, 2, 5, 7 . RNA was analysed by real-time qPCR, using the primers given in Table  S1 . For western blots, the organ powder was homogenized by sonication in lysis buffer (62.5 mM Tris HCl, 5% SDS, 10 mM EDTA, pH = 6.8). Protein content was measured using a detergent-compatible DC protein assay kit (Bio-Rad Laboratories, Reinach BL, Switzerland). Samples (30 µg) were loaded on a 10% polyacrylamide gel, separated by electrophoresis and transferred onto PVDF membranes (Immobilon-P; Millipore, Volketswil, Switzerland). Membranes were incubated for 1h in PBS or TBS containing 5% milk and 0.1% Tween 20 (blocking buffer). The membranes were then incubated overnight at 4°C with one of the following primary antibodies: rabbit polyclonal antibodies against Cx40 (Chemicon, AB1726; 1:500); Cx37 (Biotrend Chemikalien, Cx37A11-A; 1:1000); Cx43 (Cell Signaling, 3512S, 1:1000); AKT (Cell Signaling, 9272S, 1:500); mouse monoclonal antibodies against eNOS (BD Biosciences, 610297, 1:500), PeNOS (BD Biosciences, 612392, 1:500), P-AKT (Cell Signaling, 4051S, 1:500) or α-tubulin (Sigma-Aldrich, T5168; 1:2500); goat polyclonal antibodies against Cx45 (Chemicon, AB1748, 1:1000). The secondary antibodies were horseradish peroxidase-conjugated goat anti-mouse immunoglobulins (Jackson Immuno research, 63343, 1:20'000), goat anti-rabbit immunoglobulins (Thermo Scientific, 31460, 1:5'000) or rabbit anti-goat immunoglobulins (Pierce, 31402, 1:20'000), whichever adequate. Bands were developed using enhanced chemiluminescence (Millipore, Immunobilon Western Chemiluminescent HRP substrate), and visualized using a supercooled CCD camera (Chemidoc XRS, Bio-Rad Laboratories). Densitometric analysis was performed using a ImageLab Software (3.0.1 Bio-Rad Laboratories). To prepare samples enriched in either ECs or SMCs, thoracic aortas were longitudinally opened within 100 µl PBS and pinned on a silicone plate, EC-side up. A scalpel blade was then used to gently scrape off ECs in the 100 µl of PBS. Supernatants containing ECs were collected, and the remaining aorta walls, containing SMCs, were frozen in liquid nitrogen. Aliquots enriched in ECs and SMCs were homogenized in lysis buffer and processed for western blot analysis as described above. Blots are presented with bands from different experiments (delineated by black boxes), to match the average results of quantifications which integrate the densitometric analysis of multiple blots, each running several independent samples.
Immunohistochemistry and in situ proximity ligation assay
For immunolabeling, freshly excised aortas were rapidly frozen and processed for cryosectioning 2, 3, [5] [6] [7] . Cryostat sections were stained using one of the following antibodies: rabbit polyclonal against Cx40 (Chemicon, AB1726), Cx37 (Biotrend Chemikalien, Cx37A11-A) or Cx43 (Cell Signaling, 3512S); mouse monoclonal antibodies against eNOS (BD Biosciences, 610297). All antibodies were diluted 1:100. Primary antibodies were detected using antibodies to rabbit immunoglobulins labelled with AlexaFluor 488 (Invitrogen), or to mouse immunoglobulins labelled with AlexaFluor 594 (Invitrogen), both diluted 1:500. For enface immunostaining, thoracic aortas were removed, and opened longitudinally within a few drops of PBS warmed at 37°C. The vessels were then attached with micro pins on Sylgardcoated dishes, ECs up. Aortic strips were cut, fixed for 10 min in 100% ethanol, cooled at -20°C, and incubated for 30 min in a blocking solution (PBS supplemented with 5% BSA and 0.2%Triton X-100). The strips were then labelled with either rabbit polyclonal antibodies against Cx37 (Biotrend Chemikalien, Cx37A11-A; diluted 1:50), or mouse monoclonal antibodies against Cx40 (Invitrogen; diluted 1:50), eNOS (BD Biosciences, 610297, diluted 1:100). Primary antibodies were detected using antibodies to either rabbit immunoglobulins labelled with AlexaFluor 488 (Invitrogen) or to mouse immunoglobulin labelled with AlexaFluor 594 (Invitrogen). A direct interaction between eNOS and either Cx40 or Cx37 proteins was tested in the aortic endothelium using the Duolink in situ proximity ligation assay (OLINK Bioscience). Briefly, longitudinally opened aortas were fixed in 100% ethanol, and aortic strips prepared for the simultaneous incubation with a rabbit polyclonal antibody against Cx40 (Chemicon AB1726) or Cx37 (Biotrend Chemikalien, Cx37A11-A), and a mouse monoclonal antibody against eNOS (BD Biosciences 610297), diluted 1:100. The incubation solution was then supplemented with oligonucleotide-conjugated secondary antibodies (diluted 1:5) and a ligation solution, consisting of two nucleotides and a ligase, to form a circular DNA, when eNOS and one of the Cxs were in close proximity. The circular DNA was then amplified into a long, single-stranded concatemer by rolling circle amplifications, using as primer an arm of one of the oligonucleotide-conjugated antibodies. The amplification product was collapsed into a DNA bundle, and detected by hybridizing fluorophore -labeled oligonucleotides (Duolink in situ detection reagent red) to the repeated sequences of the amplification product. Under a fluorescence microscope, the result was detected as red spots, which were localized by staining the EC nuclei with DAPI, and the EC membrane with an antibody against Cx37.
Measurement of NO
Thoracic aortas from two mice were opened, EC face up, as described above. After 2 washes in 37°C PBS, the vessels were incubated for 30 min in 250 µL PBS, under a water-saturated atmosphere. The buffer and the aortas were then collected and frozen in liquid nitrogen. NO levels were detected using a QuantiChrom Nitric Oxide Assay kit (BioAssay Systems). Briefly, 100 µL of the collected samples were placed in eppendorf tubes, and processed in parallel with nitrite standards and a blank. After addition of 200 µL Working Reagent to each sample, and a 10 min incubation at 60°C, the reaction tubes were briefly centrifuged. The supernatant was transferred into 96 well plates, and absorbance read at 500-570 nm (peak 540 nm). Quantitative evaluation indicates that this interaction increased in the aortas of WT 1K1C, and decreased in the aortas of Cx40-/-and Cx40-/-1K1C mice. In all bar graphs, results are means + SEM of 3-4 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs. WT mice; °P < 0.05 vs. respective controls. In the aortas of WT mice, Cx40 and Cx37 interact with eNOS in ECs, resulting in a sizable NO production. The absence of Cx40 in Cx40-/-mice is associated with a decreased expression of both Cx37 and eNOS, resulting in a reduced production of NO. In hypertensive WT1K1C mice, the levels of Cx40 are increased, whereas those of Cx37 and eNOS are not. As a result, the interaction of Cx40 and Cx37 with eNOS, which takes place in both the cytoplasm and the cell membrane of ECs, is enhanced, leading to an increase in NO production. In contrast, the association of renin-and volume-dependent hypertension (Cx40-/-1K1C mice) decreases the expression of both Cx37 and eNOS, and enhances the phosphorylation of the enzyme, preserving the NO production, in spite of the loss of Cx40.
Statistical analysis
